Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Colorado MEDtech, Inc. Announces Second-Quarter Results and Provides Pro Forma Information to Reflect the Sale of Its Colorado Operations.


Business Editors/Health & Medical Writers

BOULDER Boulder, city, United States
Boulder, city (1990 pop. 83,312), seat of Boulder co., N central Colo.; inc. 1871. A Rocky Mountain resort and a suburb of Denver, it is the seat of the Univ. of Colorado (1876).
, Colo.--(BUSINESS WIRE)--Feb. 10, 2003

Colorado Colorado, state, United States
Colorado (kŏlərăd`ə, –răd`ō, –rä`dō), state, W central United States, one of the Rocky Mt. states.
 MEDtech, Inc. (Nasdaq:CMED CMED Coordinated Medical Emergency Direction
CMED Central Massachusetts Emergency Dispatch
) today announced results for its second quarter ended December December: see month.  31, 2002.

The Company filed information with the SEC today reflecting the sale of the Colorado operations, some of which is included below.

For the quarter ended December 31, 2002, the Company had net income of $519,000 and earnings per share, on a diluted di·lute  
tr.v. di·lut·ed, di·lut·ing, di·lutes
1. To make thinner or less concentrated by adding a liquid such as water.

2. To lessen the force, strength, purity, or brilliance of, especially by admixture.
 basis, of 4 cents. In the second quarter of the prior year, the Company had a net loss of $818,000 and a loss per share, on a diluted basis, of 6 cents. Sales in the second quarter were $14,544,000 compared to $17,688,000 for the same period in the prior year.

For the six months ended December 31, 2002, the Company had net income of $180,000 and earnings per share, on a diluted basis, of 1 cent. In the same period of the prior year, the Company had a net loss of $1,964,000 and a loss per share, on a diluted basis, of 15 cents. Sales in the six months ended December 31, 2002, were $28,677,000 compared to $34,708,000 for the same period in the prior year.

On January January: see month.  24, 2003, the Company and HEI HEI Higher Education Institution (UK)
HEI Health Effects Institute
HEI Hautes Études Internationales
HEI House Ear Institute
HEI Healthy Eating Index
HEI Hautes Etudes d'Ingénieur
HEI High-Explosive Incendiary
, Inc. entered into a purchase agreement whereby the Company sold certain of the assets and liabilities of the Colorado Operations to HEI. The assets and liabilities sold consisted primarily of cash, inventories, property and equipment, warranty An assurance, promise, or guaranty by one party that a particular statement of fact is true and may be relied upon by the other party.

Warranties are used in a variety of commercial situations. In many instances a business may voluntarily make a warranty.
 obligations and customer deposits, and had a recorded net book value of approximately ap·prox·i·mate  
adj.
1. Almost exact or correct: the approximate time of the accident.

2.
 $9.8 million. The Company sold the net assets Net assets

The difference between total assets on the one hand and current liabilities and noncapitalized long-term liabilities on the other hand.


net assets

See owners' equity.
 to HEI in exchange for 1,000,000 shares of HEI common stock, valued at approximately $2.6 million (based on the closing price of the stock on the NASDAQ market) and a $2.6 million subordinated Subordinated

A claim ranked lower in priority than other claims. Common stock claims are always subordinated to debt.
 promissory note promissory note, unconditional written promise to pay a certain sum of money at a definite time to bearer or to a specified person on his order. Promissory notes are generally used as evidence of debt.  (the "Note"). The Note has an interest rate of 10% (increasing to 12% on July July: see month.  24, 2003, and to 14% on January 24, 2004) and matures September September: see month.  30, 2004. The Company also transferred the rights and obligations of the operating lease Operating Lease

A lease contract that allows the use of an asset, but does not convey rights similar to ownership of the asset.

Notes:
An operating lease is not capitalized it is accounted for as a rental expense.
 and expansion of the facilities located in Boulder, Colorado The City of Boulder (, Mountain Time Zone) is a home rule municipality located in Boulder County, Colorado, United States. Boulder is the 11th most populous city in the State of Colorado, as well as the most populous city and the county , which had a 10-year lease commitment and future minimum lease payments Rental payments over the lease term including the amount of any bargain purchase option, premium and any guaranteed residual value and excluding any rental relating to costs to be met by the lessor and any contingent rentals.  of approximately $10.4 million for the current lease and $6.9 million for the expansion, a total obligation of approximately $17.3 million. As result of this transaction, in January 2003 the Company recorded a loss of approximately $6.4 million, and an after tax loss of approximately $4.2 million.

The Company filed a Form 8-K Form 8-K

The form required by the SEC when a publicly held company incurs any event that might affect its financial situation or the share value of its stock.


Form 8-K

See 8-K.
 on February February: see month.  10, 2003, containing pro forma As a matter of form or for the sake of form. Used to describe accounting, financial, and other statements or conclusions based upon assumed or anticipated facts.

The phrase pro forma
 information on the impact of this transaction. The Company has included the pro forma information as part of this press release to show how the transaction might have affected historical financial statements if the transaction had been consummated con·sum·mate  
tr.v. con·sum·mat·ed, con·sum·mat·ing, con·sum·mates
1.
a. To bring to completion or fruition; conclude: consummate a business transaction.

b.
 at an earlier date. The pro forma balance sheet is as of December 31, 2002, and is prepared as if the transaction with HEI, Inc. had occurred on December 31, 2002. The pro forma income statement is for the six months ended December 31, 2002, and is prepared as if the transaction with HEI, Inc. had occurred on June June: see month.  30, 2001. Both of these pro forma statements Pro forma statement

A financial statement showing the forecast or projected operating results and balance sheet, as in pro forma income statements, balance sheets, and statements of cash flows.
 are included in the Form 8-K filed February 10, 2003. These pro forma financial statements Pro forma financial statements

A firm's financial statements as adjusted to reflect a projected or planned transaction. "What-if" analysis.
 were prepared under the guidelines guidelines,
n.pl a set of standards, criteria, or specifications to be used or followed in the performance of certain tasks.
 provided by the Securities and Exchange Commission for pro forma financial statements. These pro forma statements are not intended to present what the actual financial condition or results of operations would have been had the Company previously disposed dis·pose  
v. dis·posed, dis·pos·ing, dis·pos·es

v.tr.
1. To place or set in a particular order; arrange.

2.
 of these assets and liabilities nor are they necessarily indicative indicative: see mood.  of results of operations to be achieved in future periods.

"We are very pleased to have completed the sale of the Colorado operations," said Stephen Stephen, 1097?–1154, king of England (1135–54). The son of Stephen, count of Blois and Chartres, and Adela, daughter of William I of England, he was brought up by his uncle, Henry I of England, who presented him with estates in England and France and  K. Onody, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "The business that remains is our CIVCO Medical Instruments subsidiary. During the six months ended December 31, 2002, CIVCO has reported revenues of $13.7 million and operating profits Operating profit (or loss)

Revenue from a firm's regular activities less costs and expenses and before income deductions.


operating profit

See operating income.
 of $3.0 million. We look forward to CIVCO's continued growth prospects and we expect it to report operating profits. We are continuing the process of seeking buyers for the entire company or CIVCO."

Colorado MEDtech, Inc., through its CIVCO Medical Instruments Co., Inc. subsidiary, is a full service developer and manufacturer of medical devices and equipment for the ultrasound ultrasound or sonography, in medicine, technique that uses sound waves to study and treat hard-to-reach body areas. In scanning with ultrasound, high-frequency sound waves are transmitted to the area of interest and the returning echoes recorded  and minimally invasive invasive /in·va·sive/ (-siv)
1. having the quality of invasiveness.

2. involving puncture of the skin or insertion of an instrument or foreign material into the body; said of diagnostic techniques.
 OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and  and end-user (job) end-user - The person who uses a computer application, as opposed to those who developed or support it. The end-user may or may not know anything about computers, how they work, or what to do if something goes wrong.  markets.

Conference Call

Colorado MEDtech will hold a conference call at 8:00 a.m. MST See micro systems technology.  (10:00 a.m. EST EST electroshock therapy.

EST
abbr.
electroshock therapy
) on Tuesday Tuesday: see week. , February 11, 2003, to discuss its second-quarter results. Interested parties may listen to the call by calling 800/218-9073. A replay of the call will be available until February 25, 2003, at 800/405-2236, passcode 524377#.

Forward-Looking Statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.


The statements in this news release that are not historical facts, including those regarding strategic alternatives, are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Forward-looking statements can be identified by the use of words such as "believes," "intends," "estimates," "may," "will," "should," "anticipated," "expected" or comparable terminology The terminology used in the computer and telecommunications field adds tremendous confusion not only for the lay person, but for the technicians themselves. What many do not realize is that terms are made up by anybody and everybody in a nonchalant, casual manner without any regard or  or by discussions of strategy. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot assure that these expectations will prove to be correct. Such statements involve risks and uncertainties including, but not limited to, the risk that the value of the HEI stock and subordinated debenture subordinated debenture

An unsecured bond with a claim to assets that is subordinate to all existing and future debt. Thus, in the event that the issuer encounters financial difficulties and must be liquidated, all other claims must be satisfied before
 may, in the future, be lower than the price at which the Company acquired them, the risk that such changes in fair value will result in significant charges to our income statement, the risk that the Company may be unable to successfully complete the sale of the Company or its CIVCO Medical Instruments subsidiary, the risk that the Company's existing level of orders may not be indicative of the level or trend of future orders, the risk that the Company may not successfully complete the work encompassed by current or future orders, the risk that unforeseen technical or production difficulties may adversely impact project timing and financial performance, the risk of an adverse result in pending or potential litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
, the risks associated with regulation by the Federal Food and Drug Administration including compliance with the Quality System Regulation, the risk that acquired companies cannot be successfully integrated with the Company's existing operations and the risk that a downturn Downturn

The transition point between a rising, expanding economy to a falling, contracting one.


downturn

A decline in security prices or economic activity following a period of rising or stable prices or activity.
 in general economic conditions or customer budgets may adversely affect research and development and capital expenditure budgets of potential customers upon which the Company is dependent. Should one or more of these risks materialize ma·te·ri·al·ize  
v. ma·te·ri·al·ized, ma·te·ri·al·iz·ing, ma·te·ri·al·iz·es

v.tr.
1. To cause to become real or actual: By building the house, we materialized a dream.
 (or the consequences of such a development worsen wors·en  
tr. & intr.v. wors·ened, wors·en·ing, wors·ens
To make or become worse.


worsen
Verb

to make or become worse

worsening adjn
), or should the underlying assumptions prove incorrect Incorrect means to not be correct and may also refer to:
  • Politically incorrect
  • Incorrectly formatted data, a computer error
See also
  • Correctness
  • Anomalously numbered roads in Great Britain
  • Disputes in English grammar (Incorrect English)
, actual results could differ materially from those forecasted or expected. These factors are more fully described in the Company's documents filed from time to time with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update publicly or revise such statements whether as a result of new information, future events or otherwise.


               COLORADO MEDTECH, INC. AND SUBSIDIARIES
                CONDENSED CONSOLIDATED BALANCE SHEETS
                             (UNAUDITED)

                             December 31, 2002       June 30, 2002
                             -----------------       -------------

ASSETS
------
CURRENT ASSETS:
 Cash and cash equivalents      $ 9,296,248           $ 6,366,303
 Short-term investments             594,626               993,319
 Accounts receivable, net         5,703,213             9,644,164
 Unbilled receivables               385,361               169,438
 Inventories                      5,048,322             5,781,665
 Income taxes receivable          3,279,972             3,589,907
 Deferred income taxes            1,557,803             1,557,803
 Prepaid expenses and other         594,365               824,563
                                 ----------            ----------
   Total current assets          26,459,910            28,927,162

NON-CURRENT ASSETS:
 Property and equipment, net      6,098,673             5,700,043
 Goodwill and other intangibles,
  net                             6,172,417             5,876,785
 Land held for sale                 500,000               500,000
 Deferred income taxes            1,227,143             1,227,143
 Other assets                       315,273               302,726
                                 ----------            ----------
   Total non-current assets      14,313,506            13,606,697

TOTAL ASSETS                    $40,773,416           $42,533,859
                                 ==========            ==========

LIABILITIES AND SHAREHOLDERS' EQUITY
------------------------------------
CURRENT LIABILITIES:
 Accounts payable               $ 3,052,705           $ 4,878,784
 Accrued product service costs      386,149               376,907
 Accrued salaries and wages       1,704,501             1,989,815
 Other accrued expenses           1,749,787             1,435,222
 Customer deposits and deferred
  revenue                         1,342,326             1,733,746
 Capital lease obligation            11,380                33,503
                                 ----------            ----------
   Total liabilities              8,246,848            10,447,977

SHAREHOLDERS' EQUITY:
 Preferred stock, no par value;
  5,000,000 shares authorized;
  none issued
 Common Stock, no par value,
  25,000,000 shares authorized;
  13,256,959 and 13,168,783
  issued and outstanding at
  December 31, 2002 and June 30,
  2002, respectively             16,882,820           16,718,092
 Accumulated other
  comprehensive loss                 (1,691)              (7,432)
 Notes receivable -- related
  parties                          (609,799)            (699,799)
 Retained earnings               16,255,238           16,075,021
                                 ----------           ----------
   Total shareholders' equity    32,526,568           32,085,882
                                 ----------           ----------
TOTAL LIABILITIES AND
 SHAREHOLDERS' EQUITY           $40,773,416          $42,533,859
                                 ==========           ==========



                COLORADO MEDTECH, INC. AND SUBSIDIARIES
            CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 FOR THE THREE AND SIX MONTH PERIODS ENDED DECEMBER 31, 2002 AND 2001

                             (UNAUDITED)

                          Three Months Ended       Six Months Ended
                             December 31,             December 31,
                          ------------------       ----------------
                           2002        2001        2002        2001
                           ----        ----        ----        ----

NET REVENUE:
 Outsourcing Services $ 3,624,533 $ 6,946,866 $ 7,222,298 $13,281,834
 Medical Products      10,919,241  10,741,452  21,454,803  21,425,827
                       ----------  ----------  ----------  ----------
 Total net revenue     14,543,774  17,688,318  28,677,101  34,707,661
                       ----------  ----------  ----------  ----------

COST OF PRODUCTS AND SERVICES:
 Outsourcing Services   3,777,828   6,731,234   7,819,632  12,286,236
 Medical Products       6,420,143   6,065,237  12,868,910  12,698,489
                       ----------  ----------  ----------  ----------
 Total cost of products
  and services         10,197,971  12,796,471  20,688,542  24,984,725
                       ----------  ----------  ----------  ----------

GROSS PROFIT            4,345,803   4,891,847   7,988,559   9,722,936
                       ----------  ----------  ----------  ----------

COSTS AND EXPENSES:
 Research and
  development             447,123   1,035,347     947,320   1,867,606
 Marketing and selling    835,106     966,069   1,891,805   1,954,039
 Operating, general and
  administrative        2,008,035   3,775,319   4,426,982   8,140,816
 Other operating
  expenses                224,383     470,530     494,189   1,067,510
                       ----------  ----------  ----------  ----------
    Total operating
     expenses           3,514,647   6,247,265   7,760,296  13,029,971
                       ----------  ----------  ----------  ----------

INCOME (LOSS) FROM
 OPERATIONS               831,156  (1,355,418)    228,263  (3,307,035)

OTHER INCOME, net           5,420      35,104      70,954     135,868
                       ----------  ----------  ----------  ----------

INCOME (LOSS) BEFORE
 INCOME TAXES             836,576  (1,320,314)    299,217  (3,171,167)

INCOME TAX EXPENSE
 (BENEFIT)                318,000    (502,000)    119,000  (1,207,000)
                       ----------  ----------  ----------  ----------

NET INCOME (LOSS)     $   518,576 $  (818,314)$   180,217 $(1,964,167)
                       ==========  ==========  ==========  ==========

NET INCOME (LOSS) PER SHARE
 Basic and diluted          $ .04      $ (.06)      $ .01      $ (.15)
                             ====       =====        ====       =====

WEIGHTED AVERAGE SHARES
 OUTSTANDING
 Basic and diluted     13,169,741  12,963,968  13,169,262  12,967,347
                       ==========  ==========  ==========  ==========



The following unaudited pro forma statements represent the December 31, 2002, balance sheet adjusted to reflect the sale of the assets and liabilities of the Colorado operations to HEI as if such sale had taken place on December 31, 2002:


                      Consolidated     Pro Forma         Pro Forma
          ASSETS    December 31, 2002 Adjustments    December 31, 2002
                    ----------------- -----------    -----------------

CURRENT ASSETS:
 Cash and cash
  equivalents          $ 9,296,000    $(5,315,000) a     $ 3,981,000
 Short-term
  investments              595,000              -            595,000
 Accounts receivable,
  net                    5,703,000              -          5,703,000
 Unbilled receivables      385,000       (340,000) a          45,000
 Inventories             5,048,000     (2,688,000) a       2,360,000
 Income taxes receivable 3,280,000      3,760,000 d,k      7,040,000
 Deferred income taxes   1,558,000     (1,152,000) k         406,000
 Prepaid expenses and
  other                    595,000       (328,000) a         267,000
                        ----------     ----------         ----------
   Total current assets 26,460,000     (6,063,000)        20,397,000
                        ----------     ----------         ----------

NON-CURRENT ASSETS:
 Property and equipment,
  net                    6,099,000     (1,822,000) a       4,277,000
 Goodwill and
  intangibles, net       6,172,000              -          6,172,000
 Investment in HEI
  stock                          -      2,483,000 b,c      2,483,000
 Promissory note, HEI            -      2,600,000  b       2,600,000
 Land held for sale        500,000              -            500,000
 Deferred income taxes   1,227,000       (522,000) k         705,000
 Other assets              315,000        (80,000) a         235,000
                        ----------     ----------         ----------
   Total non-current
    assets              14,313,000      2,659,000         16,972,000
                        ----------     ----------         ----------

   TOTAL ASSETS        $40,773,000    $(3,404,000)       $37,369,000
                        ==========     ==========         ==========

   LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
 Accounts payable      $ 3,053,000    $ 1,025,000 e,f    $ 4,078,000
 Accrued product
  service cost             386,000       (376,000) a          10,000
 Accrued salaries and
  wages                  1,705,000        800,000 h,i      2,505,000
 Other accrued expenses  1,750,000       (290,000) g       1,460,000
 Customer deposits and
  deferred revenue       1,342,000       (515,000) a         827,000
 Capital lease obligation   11,000              -             11,000
                        ----------     ----------         ----------
   Total liabilities     8,247,000        644,000          8,891,000
                        ----------     ----------         ----------

SHAREHOLDERS' EQUITY
 Common stock           16,883,000              -         16,883,000
 Accumulated other
  comprehensive loss        (2,000)             -             (2,000)
 Notes receivable --
  related parties         (610,000)             -           (610,000)
 Retained earnings      16,255,000     (4,048,000) j      12,207,000
                        ----------     ----------         ----------
   Total shareholders'
    equity              32,526,000     (4,048,000)        28,478,000
                        ----------     ----------         ----------
TOTAL LIABILITIES AND
 SHAREHOLDER'S EQUITY  $40,773,000    $(3,404,000)       $37,369,000
                        ==========     ==========         ==========

Pro forma adjustments to reflect the sale of the Colorado operations
to HEI:

    a. assets and liabilities sold to HEI under the purchase agreement
    b. subordinated promissory note ($2.6 million) and common stock
($2.6 million) received by the Company as consideration for the
Colorado operations
    c. payment to landlord of $117,000 paid in the form of HEI common
stock
    d. taxes receivable resulting from the loss on the sale of the
Colorado operations, carried back against taxable gains earned in the
last five years of approximately $2,086,000
    e. investment banking, legal and accounting fees incurred and
accrued as part of the transaction of approximately $950,000
    f. Colorado MEDtech's portion of the sales and use taxes on the
transaction of approximately $75,000
    g. relief of accrued future rent obligation for the Colorado
operations' leased facility
    h. Colorado MEDtech holdback for employees leased to HEI for one
week $300,000
    i. severance accrued for additional personnel reductions $500,000
    j. loss on HEI transaction, assuming the transaction occurred on
December 31, 2002
    k. deferred tax assets that will become income tax receivables as
a result of the sale of Colorado operations



The following unaudited pro forma statement of operations for the six months ended December 31, 2002, represents the results as if the sale to HEI occurred on June 30, 2001:


                                                         Pro Forma
                   Six Months Ended    Pro Forma      Six Months Ended
                   December 31, 2002  Adjustments    December 31, 2002
                   -----------------  -----------    -----------------

NET REVENUE
 Outsourcing services  $ 7,222,000    $(7,222,000) l     $         -
 Medical products       21,455,000     (7,773,000) l      13,682,000
                        ----------     ----------         ----------
   Total net revenue    28,677,000    (14,995,000)        13,682,000
                        ----------     ----------         ----------

COST OF PRODUCTS AND SERVICES
 Outsourcing services    7,820,000     (7,820,000) l               -
 Medical products       12,869,000     (6,035,000) l       6,834,000
                        ----------      ---------         ----------
   Total cost of
    products and
    services            20,689,000    (13,855,000)         6,834,000
                        ----------     ----------         ----------
GROSS PROFIT             7,988,000     (1,140,000)         6,848,000
                        ----------     ----------         ----------
OPERATING EXPENSES
 Research and
  development              947,000       (624,000) l         323,000
 Marketing and selling   1,892,000     (1,171,000) l         721,000
 Operating, general and
  administrative         4,427,000     (1,661,000) l       2,766,000
 Other operating expense   494,000       (494,000) l               -
                        ----------     ----------         ----------
   Total operating
    expenses             7,760,000     (3,950,000)         3,810,000
                        ----------     ----------         ----------
NET INCOME (LOSS)
 FROM OPERATIONS           228,000      2,810,000          3,038,000

OTHER INCOME (EXPENSE)
 Other income, net          71,000        (50,000) m,n        21,000
 Unrealized holding gains
  (losses) in HEI Stock          -     (1,228,000)  o     (1,228,000)
 Interest income on
  subordinated note
  from HEI                       -        182,000   p        182,000
                        ----------     ----------         ----------

   Total other income
    (expense)               71,000     (1,096,000)        (1,025,000)
                        ----------     ----------         ----------

INCOME (LOSS) BEFORE
 TAXES                     299,000      1,714,000          2,013,000
INCOME TAX EXPENSE
 (BENEFIT)                 119,000        651,000            770,000
                        ----------     ----------         ----------
NET INCOME (LOSS)      $   180,000    $ 1,063,000        $ 1,243,000
                        ==========     ==========         ==========

NET INCOME (LOSS) PER SHARE
 Basic and diluted           $ .01          $ .08              $ .09
                              ====           ====               ====

WEIGHTED AVERAGE SHARES
 OUTSTANDING
 Basic and diluted      13,169,262     13,169,262         13,169,262
                        ==========     ==========         ==========

Pro forma adjustments to reflect the sale of the Colorado Operations
to HEI:

    l. elimination of operating results of the Colorado operations
    m. removal of interest income on the $5,600,00 of cash sold to HEI
at an average rate of 1.5% per annum
    n. removal of interest income on officer loans for officers who
left Colorado MEDtech as a direct result of the sale of the Colorado
operations
    o. change in HEI stock price from $7.70 per share at June 30, 2002
to $3.20 per share at December 31, 2002, based upon the purchase of
$2,6 million of stock at June 30, 2001
    p. interest income on subordinated promissory note from HEI, Inc.
at approximately $182,000

COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U8CO
Date:Feb 10, 2003
Words:2837
Previous Article:Pope Resources Reports 2002 Fourth Quarter Earnings of $0.7 Million.
Next Article:Alliance Resource Partners, L.P. Completes Public Offering of Partnership Units.
Topics:



Related Articles
Colorado MEDtech Inc. Announces Second Quarter and Six-month Results.
Colorado MEDtech, Inc. Announces Fourth Quarter and Fiscal Year-End Results, Management Changes and Stock Repurchase Program.
Colorado MEDtech, Inc. Announces First Quarter Results.
Colorado MEDtech, Inc. Comments On Expected Second Quarter Results.
Colorado MEDtech, Inc. Announces Increased Revenues for the Third Quarter.
Colorado MEDtech, Inc. Announces First-Quarter Results.
Colorado MEDtech, Inc. Announces Third Quarter Results.
Colorado MEDtech, Inc. Provides Further Details On Sale of Its Colorado Operations.
Colorado MEDtech, Inc. Announces Resignation of Member of Board of Directors.
Colorado MEDtech, Inc. Announces Third-Quarter Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles